Home News & Events News overview The CE Marking process and Factory CRO

Leonie van de Kamer

Clinical Study Manager

March 21, 2016

The CE Marking process and Factory CRO

The CE-mark serves the goal of free movement of many goods throughout the European Economic Area. You may have seen the mark somewhere, for example on the back of your phone, your laptop or a toy product. The display of the CE-mark on a medical device means that the device meets all applicable requirements of European Directive 93/42/EEC, or Medical Devices Directive. This Directive dictates a particular result that needs to be achieved, without dictating the means of achieving this. For example, one dictated (Essential) requirement in this directive is to have a Quality Management System in place – click here for more information.

Many studies conducted under contract of Factory CRO serve the goal of gathering safety and efficacy data in order to, eventually, CE-mark the medical device. For medical devices classified as IIa and higher, the requirements for these studies are usually determined in cooperation with a Notified Body. The Notified Body is an independent third party which is delegated by EU Member States for the conformity assessment of products. It is the party that certifies the manufacturer for meeting all CE-marking requirements. Examples of Notified Bodies for medical devices are The British Standards Institution (BSI) and the various Technischer Überwachungsverein (TÜV).

After the manufacturers and Notified Bodies agree upon the strategy towards CE-marking, this strategy will be put into practice. Factory CRO may provide several types of services here, including monitoring, regulatory services, data management activities, etc. Subsequent to these specific trials, the process of self-certification, in which the manufacturer declares the product conform the Medical Devices Directive, will be conducted and the medical device can be marketed.

Recommendation: Your medical device may require conformity assessment by a Notified Body before self-certification of the product for marketing in the European Economic Area can take place. Learn more? Click here

By Leonie van de Kamer and Tim Sinnema

About the author

Leonie van de Kamer Clinical Study Manager

Leonie is a Clinical Study Manager at Factory-CRO with a thorough mindset and a fine eye for potential growth opportunities. Her expertise lies within the field of Regulatory Affairs & Clinical Trials for Medical Devices. Also, she is involved in business development and would be happy to provide you with custom-made advice.

March 21, 2018

Clinical Investigations – What changes because of the Medical Device Regulation?

  Does the MDR change your Clinical Investigations? April 5th 2017 was a historical moment for the medical device industry: the Medical Device Regulation (MDR) was adopted by the European Union. Beginning May 27th, 2020, after a 3 year transition...

Pre Market
February 27, 2018

One Medical Device Trial Fits All! ISO 14155 as a Standard for Your Foreign Data Submitted to the FDA

There is interesting news in the medical device world that may impact your clinical strategy! On February 21, 2018, the FDA released its final ruling on the acceptance of data from clinical investigations for medical devices. With this amendment to...

Pre Market
February 8, 2018

Earn and Keep Your Market Share Through Reimbursement Support

Market adoption of new medical devices in the United States is largely dependent on the availability of an applicable CPT® code for use in reporting the services provided. Additionally, the existence of positive insurance medical policies outlining coverage for a...

Pre Market